Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides. 2016

Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
Department of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China. xichunpan@163.com.

Toll-like receptor (TLR) 9 is an endosomal receptor recognizing bacterial DNA/CpG-containing oligodeoxynucleotides (CpG ODN). Blocking CpG ODN/TLR9 activity represents a strategy for therapeutic prevention of immune system overactivation. Herein, we report that a synthetic peptide (SP) representing the leucine-rich repeat 11 subdomain of the human TLR9 extracellular domain could attenuate CpG ODN/TLR9 activity in RAW264.7 cells by binding to CpG ODN and decreasing its internalization. Our results demonstrate that preincubation with SP specifically inhibited CpG ODN- but not lipopolysaccharide (LPS)- and lipopeptide (PAM3CSK4)-stimulated TNF-α and IL-6 release. Preincubation of SP with CpG ODN dose-dependently decreased TLR9-driven phosphorylation of IκBα and ERK and activation of NF-κB/p65. Moreover, SP dose-dependently decreased FAM-labeled CpG ODN internalization, whereas non-labeled CpG ODN reversed the inhibition. The KD value of SP-CpG ODN binding was within the micromolar range. Our results demonstrated that SP was a specific inhibitor of CpG ODN/TLR9 activity via binding to CpG ODN, leading to reduced ODN internalization and decreased activation of subsequent pathways within cells. Thus, SP could be used as a potential CpG ODN antagonist to block TLR9 signaling.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
January 2007, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
January 2010, Journal of innate immunity,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
January 2004, Oligonucleotides,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
August 2010, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
December 2023, Molecular therapy. Nucleic acids,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
January 2013, Nature communications,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
September 2011, Journal of immunology (Baltimore, Md. : 1950),
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
January 2013, PloS one,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
October 2011, European journal of immunology,
Xichun Pan, and Bin Li, and Mei Kuang, and Xin Liu, and Yanyan Cen, and Rongxin Qin, and Guofu Ding, and Jiang Zheng, and Hong Zhou
March 2004, Human immunology,
Copied contents to your clipboard!